Why the study?
Are plasma levels of NproANP a more sensitive marker of left ventricular dysfunction than ANP in patients with congestive heart failure?
Are plasma levels of NproANP a more sensitive marker of left ventricular dysfunction than ANP in patients with congestive heart failure?
NproANP plasma levels may be a more sensitive marker of early left ventricular dysfunction than ANP in patients with congestive heart failure.
Authors
No takes yet. Share an insight, caveat, or question.
NproANP may detect early LV dysfunction more sensitively than ANP; leaves open clinical adoption pending prospective validation.
Azizi et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: